AI-Designed shake takes on type 2 diabetes in new clinical trial
NCT ID NCT07622628
First seen Jun 05, 2026 · Last updated Jun 12, 2026 · Updated 3 times
Summary
This study tests whether a nutritional drink, designed using artificial intelligence, can help adults with type 2 diabetes lower their blood sugar levels. About 100 people will receive either the active drink or a placebo for 24 weeks, alongside their usual diabetes care. The main goal is to see if the drink leads to a greater drop in HbA1c, a key blood sugar marker, compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bakırçay University Faculty of Medicine Endocrinology Department
RECRUITINGIzmir, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.